These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34759910)

  • 1. Comparison of CRISPR-Cas Immune Systems in Healthcare-Related Pathogens.
    Mortensen K; Lam TJ; Ye Y
    Front Microbiol; 2021; 12():758782. PubMed ID: 34759910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of CRISPR-Cas system in the diagnosis and therapy of ESKAPE infections.
    Qian Y; Zhou D; Li M; Zhao Y; Liu H; Yang L; Ying Z; Huang G
    Front Cell Infect Microbiol; 2023; 13():1223696. PubMed ID: 37662004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens.
    Saha U; Gondi R; Patil A; Saroj SD
    Mol Biotechnol; 2023 Jan; 65(1):1-16. PubMed ID: 35939207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CRISPR/Cas system as an antimicrobial resistance strategy in aquatic ecosystems.
    Gupta SS; Hamza Kh M; Sones CL; Zhang X; Sivaraman GK
    Funct Integr Genomics; 2024 May; 24(3):110. PubMed ID: 38806846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity and dynamics of the CRISPR-Cas systems associated with Bacteroides fragilis in human population.
    Lam TJ; Mortensen K; Ye Y
    BMC Genomics; 2022 Aug; 23(1):573. PubMed ID: 35953824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome plasticity as a paradigm of antibiotic resistance spread in ESKAPE pathogens.
    Das S; Bombaywala S; Srivastava S; Kapley A; Dhodapkar R; Dafale NA
    Environ Sci Pollut Res Int; 2022 Jun; 29(27):40507-40519. PubMed ID: 35349073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update.
    Bakhtiyari N; Farajnia S; Ghasemali S; Farajnia S; Pormohammad A; Saeidvafa S
    Infect Disord Drug Targets; 2024; 24(6):e260124226226. PubMed ID: 38284691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies.
    González de Aledo M; González-Bardanca M; Blasco L; Pacios O; Bleriot I; Fernández-García L; Fernández-Quejo M; López M; Bou G; Tomás M
    Antibiotics (Basel); 2021 Jun; 10(7):. PubMed ID: 34206474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets.
    Brooks LE; Ul-Hasan S; Chan BK; Sistrom MJ
    mSystems; 2018; 3(3):. PubMed ID: 29719870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital.
    Pandey R; Mishra SK; Shrestha A
    Infect Drug Resist; 2021; 14():2201-2212. PubMed ID: 34163185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phylogenetic Distribution of CRISPR-Cas Systems in Antibiotic-Resistant Pseudomonas aeruginosa.
    van Belkum A; Soriaga LB; LaFave MC; Akella S; Veyrieras JB; Barbu EM; Shortridge D; Blanc B; Hannum G; Zambardi G; Miller K; Enright MC; Mugnier N; Brami D; Schicklin S; Felderman M; Schwartz AS; Richardson TH; Peterson TC; Hubby B; Cady KC
    mBio; 2015 Nov; 6(6):e01796-15. PubMed ID: 26604259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of CRISPR-Cas Systems and Their Possible Association with Antibiotic Resistance in
    Alduhaidhawi AHM; AlHuchaimi SN; Al-Mayah TA; Al-Ouqaili MTS; Alkafaas SS; Muthupandian S; Saki M
    Infect Drug Resist; 2022; 15():1143-1154. PubMed ID: 35340673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017-2018).
    Ruekit S; Srijan A; Serichantalergs O; Margulieux KR; Mc Gann P; Mills EG; Stribling WC; Pimsawat T; Kormanee R; Nakornchai S; Sakdinava C; Sukhchat P; Wojnarski M; Demons ST; Crawford JM; Lertsethtakarn P; Swierczewski BE
    BMC Infect Dis; 2022 Aug; 22(1):695. PubMed ID: 35978294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas is associated with fewer antibiotic resistance genes in bacterial pathogens.
    Pursey E; Dimitriu T; Paganelli FL; Westra ER; van Houte S
    Philos Trans R Soc Lond B Biol Sci; 2022 Jan; 377(1842):20200464. PubMed ID: 34839714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania.
    Peneş NO; Muntean AA; Moisoiu A; Muntean MM; Chirca A; Bogdan MA; Popa MI
    Rom J Morphol Embryol; 2017; 58(3):909-922. PubMed ID: 29250670
    [TBL] [